Advances in Traditional Medicine

Kyung Hee Oriental Medicine Research Center (경희대학교 융합한의과학연구소)
권호 표지
DOI QR코드

DOI QR Code

A novel therapeutic approach of Hachimi-jio-gan to diabetes and its complications

  • Yokozawa, Takako (Institute of Natural Medicine, Toyama Medical and Pharmaceutical University) ;
  • Yamabe, Noriko (Institute of Natural Medicine, Toyama Medical and Pharmaceutical University) ;
  • Cho, Eun-Ju (Department of Food Science and Nutrition, Pusan National University)
  • Published : 2005.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Great efforts have been made to improve both the quality of life and life expectancy of diabetes by treating problems associated with chronic complications such as neuropathy, retinopathy and nephropathy. In particular, diabetes is an increased risk of developing several types of kidney disease, and the predominant cause of end-stage renal disease in patients with this disorder is diabetic nephropathy. Therefore, prevention of the occurrence and progression of diabetes and its complications has become a very important issue. The scientific observations of an animal model of streptozotocin-induced diabetes, spontaneously occurring diabetes and diabetic nephropathy in this study suggest that one of the Kampo prescriptions, Hachimi-jio-gan comprising eight constituents, is a novel therapeutic agent.

Keywords

References

  1. Adler S. (1997) Structure-function relationships in diabetic nephropathy: lessons and limitations. Kidney Int. 52, S42-S45.
  2. Alaveras AE, Thomas SM, Sagriotis A, Viberti GC. (1997) Promoters of progression of diabetic nephropathy: the relative roles of blood glucose and blood pressure control. Nephrol. Dial. Transplant. 12(2), 71-74. https://doi.org/10.1093/ndt/12.1.71
  3. Asplund K, Grankvist K, Marklund S, Taljedal IB. (1984) Partial protection against streptozotocin-induced hyperglycaemia by superoxide dismutase linked to polyethylene glycol. Acta Endocrinol. 107, 390-394.
  4. Baynes JW. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412. https://doi.org/10.2337/diabetes.40.4.405
  5. Baynes JW, Thorpe SR. (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48, 1-9. https://doi.org/10.2337/diabetes.48.1.1
  6. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. P. Natl. Acad. Sci. USA 87, 1620-1624. https://doi.org/10.1073/pnas.87.4.1620
  7. Bell DS. (1991) Diabetic nephropathy: changing concepts of pathogenesis and treatment. Am. J. Med. Sci. 301, 195-200. https://doi.org/10.1097/00000441-199103000-00009
  8. Brownlee M, Cerami A. (1981) The biochemistry of the complications of diabetes mellitus. Annu. Rev. Biochem. 50, 385-432. https://doi.org/10.1146/annurev.bi.50.070181.002125
  9. Brownlee M, Vlassara H, Cerami A. (1984) Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101, 527-537.
  10. Bunn HF, Gabbay KH, Gallop PM. (1978) The glycosylation of hemoglobin: relevance to diabetes mellitus. Science 200, 21-27. https://doi.org/10.1126/science.635569
  11. Ceriello A. (2000) Oxidative stress and glycemic regulation. Metabolism 49(1), 27-29. https://doi.org/10.1016/S0026-0495(00)80082-7
  12. Cooper ME. (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352, 213-219. https://doi.org/10.1016/S0140-6736(98)01346-4
  13. Cooper ME, Gilbert RE, Jerums G. (1997) Diabetic vascular complications. Clin. Exp. Pharmacol. Physiol. 24, 770-775. https://doi.org/10.1111/j.1440-1681.1997.tb02130.x
  14. Cooper ME, Gilbert RE, Epstein M. (1998) Pathophysiology of diabetic nephropathy. Metabolism 47(1), 3-6. https://doi.org/10.1016/S0026-0495(98)90184-6
  15. Corbett JA, McDaniel ML. (1992) Does nitric oxide mediate autoimmune destruction on ${\beta}$-cells? Possible therapeutic interventions in IDDM. Diabetes 41, 897-903. https://doi.org/10.2337/diabetes.41.8.897
  16. Craven PA, DeRubertis FR, Kagan VE, Melhem M, Studer RK. (1997) Effects of supplementation with vitamin C or E on albuminuria, glomerular TGF-beta, and glomerular size in diabetes. J. Am. Soc. Nephrol. 8, 1405-1414.
  17. Derubertis FR, Craven PA. (1994) Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43, 1-8. https://doi.org/10.2337/diabetes.43.1.1
  18. Fumo P, Kuncio GS, Ziyadeh FN. (1994) PKC and high glucose stimulate collagen ${\alpha}1$ (IV) transcriptional activity in a reporter mesangial cell line. Am. J. Physiol. 267, F632-F638.
  19. Furuya Y, Kawakita T, Tajima S. (1999) Effect of Hachimi-jio-gan (Ba-Wei-Di-Huang-Wan) on insulin resistance in non-insulin dependent diabetes mellitus model mice. J. Trad. Med. 16, 123-128.
  20. Giugliano D, Ceriello A, Paolisso G. (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19, 257-267. https://doi.org/10.2337/diacare.19.3.257
  21. Goldfarb S, Ziyadeh FN, Kern EF, Simmons DA. (1991) Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats. Diabetes 40, 465-471. https://doi.org/10.2337/diabetes.40.4.465
  22. Goto M, Inoue H, Seyama Y, Yamashita S, Inoue O, Yumioka E. (1989) Comparative effects of traditional Chinese medicines (dai-saiko-to, hatimi-zio-gan and byakko-ka-ninzin-to) on experimental diabetes and hyperlipidemia. Nippon Yakurigaku Zasshi 93, 179-186. https://doi.org/10.1254/fpj.93.179
  23. Ha H, Kim KH. (1995) Role of oxidative stress in the development of diabetic nephropathy. Kidney Int. 51, S18-S21.
  24. Halliwell B, Gutteridge JM, Cross CE. (1992) Free radicals, antioxidants, and human disease: Where are we now? J. Lab. Clin. Med. 119, 598-620.
  25. Hamada Y, Araki N, Koh N, Nakamura J, Horiuchi S, Hotta N. (1996) Rapid formation of advanced glycation end products by intermediate metabolites of glycolytic pathway and polyol pathway. Biochem. Bioph. Res. Co. 228, 539-543. https://doi.org/10.1006/bbrc.1996.1695
  26. Haranaka R, Mochizuki N, Watabe S, Ohwada S, Kosoto H, Kakemura H, Kuwabara Y, Hirose N, Hasegawa R, Kobayashi M. (1982) Studies of Ba-wei-wan. Part I. Lipid and carbohydrate metabolism in aged rat and mice. Proc. Symp. WAKAN-YAKU 15, 15-20.
  27. Huang T. (1997) A Handbook of Traditional Chinese Prescriptions of Dubious and Complicated Cases, pp. 527-538, China Medical and Pharmaceutical Science and Technology Publishing House, Beijing, China.
  28. Ignotz RA, Endo T, Massague J. (1987) Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-${\beta}$. J. Biol. Chem. 262, 6443-6446.
  29. Ishizaki M, Masuda Y, Fukuda Y, Yamanaka N, Masugi Y, Shichinohe K, Nakama K. (1987) Renal lesions in a strain of spontaneously diabetic WBN/Kob rats. Acta Diabetol. Lat. 24, 27-35. https://doi.org/10.1007/BF02732050
  30. Kakimoto M, Inoguchi T, Sonta T, Yu HY, Imamura M, Etoh T, Hashimoto T, Nawata H. (2002) Accumulation of 8-hydroxy-2'-deoxyguanosine and mitochondrial DNA deletion in kidney of diabetic rats. Diabetes 51, 1588-1595. https://doi.org/10.2337/diabetes.51.5.1588
  31. Kakkar R, Kalra J, Mantha SV, Prasad K. (1995) Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol. Cell Biochem. 151, 113-119. https://doi.org/10.1007/BF01322333
  32. Karpen CW, Pritchard KA Jr, Arnold JH, Cornwell DG, Panganamala RV. (1982) Restoration of the prostacyclin/thromboxane $A_2$ balance in the diabetic rat: influence of vitamin E. Diabetes 31, 947-951.
  33. Kimura Y, Okuda H, Arichi S. (1987) Effects of Japanese and Chinese traditional medicine "hachimi-gan" ("ba-wei-wan") on lipid metabolism in rats fed high sugar diet. Planta Med. 53, 128-131. https://doi.org/10.1055/s-2006-962653
  34. King GL. (1996) The role of hyperglycemia and hyperinsulinaemia in causing vascular dysfunction in diabetes. Ann. Med. 28, 427-432. https://doi.org/10.3109/07853899608999103
  35. Koya D, Lee IK, Ishii H, Kanoh H, King GL. (1997) Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol. J. Am. Soc. Nephrol. 8, 426-435.
  36. Kramer-Guth A, Quaschning T, Greiber S, Wanner C. (1996) Potential role of lipids in the progression of diabetic nephropathy. Clin. Nephrol. 46, 262-265.
  37. Kubisch HM, Wang J, Bray TM, Phillips JP. (1997) Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic ${\beta}$-cells against oxidative stress. Diabetes 46, 1563-1566. https://doi.org/10.2337/diabetes.46.10.1563
  38. Larkins RG, Dunlop ME. (1992) The link between hyperglycemia and diabetic nephropathy. Diabetologia 35, 499-504. https://doi.org/10.1007/BF00400475
  39. Loven D, Schedl H, Wilson H, Oaabees TT, Stegink LD, Diekus M, Oberley L. (1986) Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozocin-induced diabetes. Diabetes 35, 503-507. https://doi.org/10.2337/diabetes.35.5.503
  40. Lu M, Kuroki M, Amano S, Tolentino M, Keough K, Kim I, Bucala R, Adamis AP. (1998) Advanced glycation end products increase retinal vascular endothelial growth factor expression. J. Clin. Invest. 101, 1219-1224. https://doi.org/10.1172/JCI1277
  41. Luo WQ, Kanno T, Winarto A, Iwanaga T, Jun L, Futai Y, Yanaihara C, Yanaihara N. (1998) An experimental analysis of therapeutic effects of a Chinese herbal prescription in streptozotocin-treated rats. Biomed. Res. 19, 127-133.
  42. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Molvig J, Pociot F, Johannesen J, Nerup J. (1990) Cytokine and free radicals as effector molecules in the destruction of pancreatic ${\beta}$ cells. Curr. Top. Microbiol. Immunol. 164, 169-193.
  43. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, Goetz FC. (1984) Structural-functional relationships in diabetic nephropathy. J. Clin. Invest. 74, 1143-1155. https://doi.org/10.1172/JCI111523
  44. McFarland KF, Catalano EW, Day JF, Thorpe SR, Baynes JW. (1979) Nonenzymatic glucosylation of serum proteins in diabetes mellitus. Diabetes 28, 1011-1014. https://doi.org/10.2337/diabetes.28.11.1011
  45. Mochizuki N, Haranaka R, Watabe S, Ohwada S, Kosato H, Takemura H, Takanashi K, Hyon CS, Hasegawa R, Kobayashi M. (1982) Studies of Ba-wei-wan. Part II. Cholesterol metabolism in aged rats and mice using 1,2-$^{3}H$ cholesterol and 4-$^{14}C$ cholesterol. Proc. Symp. WAKAN-YAKU 15, 21-25.
  46. Mori Y, Yokoyama J, Nishimura M, Oka H, Mochio S, Ikeda Y. (1992) Development of diabetic complications in a new diabetic strain of rat(WBN/Kob). Pancreas 7, 569-577. https://doi.org/10.1097/00006676-199209000-00010
  47. Mulec H, Johnsen SA, Wiklund O, Bjorck S. (1993) Cholesterol: A renal risk factor in diabetic nephropathy? Am. J. Kidney Dis. 22, 196-201.
  48. Nagayoshi S, Nishiura T, Hagiwara Y. (1966) Effect of Hachimijio-to on the alloxan diabetes. J. Jpn. Soc. Orient. Med. 17, 236-239.
  49. Nakagawa T, Yokozawa T, Terasawa K. (2001) A study of Kampo medicines in a diabetic nephropathy model. J. Trad. Med. 18, 161-168.
  50. Nath KA, Grande J, Croatt A, Haugen J, Kim Y, Rosenberg ME. (1998) Redox regulation of renal DNA synthef?is, transforming growth factor-${\beta}_1$ and collagen gene expression. Kidney Int. 53, 367-381. https://doi.org/10.1046/j.1523-1755.1998.00778.x
  51. Niwa T. (1997) ${\beta}_2$-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products. Nephron 76, 373-391. https://doi.org/10.1159/000190218
  52. Njoroge FG, Monnier VM. (1989) The chemistry of the Maillard reaction under physiological conditions: a review. Prog. Clin. Biol. Res. 304, 85-107.
  53. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betteridge DJ. (1997) Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40, 647-653. https://doi.org/10.1007/s001250050729
  54. Oberley LW. (1988) Free radicals and diabetes. Free Radic. Biol. Med. 5, 113-124. https://doi.org/10.1016/0891-5849(88)90036-6
  55. Raj DS, Choudhury D, Welbourne TC, Levi M. (2000) Advanced glycation end products: A neurologist's perspective. Am. J. Kidney Dis. 35, 365-380. https://doi.org/10.1016/S0272-6386(00)70189-2
  56. Reddi AS, Camerini-Davalos RA. (1990) Diabetic nephropathy. An update. Arch. Intern. Med. 150, 31-43. https://doi.org/10.1001/archinte.150.1.31
  57. Saito T. (1997) Abnormal lipid metabolism and renal disorders. Tohoku J. Exp. Med. 181, 321-337. https://doi.org/10.1620/tjem.181.321
  58. Salahudeen AK, Kanji V, Reckelhoff JF, Schmidt AM. (1997) Pathogenesis of diabetic nephropathy: a radical approach. Nephrol. Dial. Transplant. 12, 664-668. https://doi.org/10.1093/ndt/12.4.664
  59. Sato Y, Hotta N, Sakamoto N, Matsuoka S, Ohishi N, Yagi K. (1979) Lipid peroxide level in plasma of diabetic patients. Biochem. Med. 21, 104-107. https://doi.org/10.1016/0006-2944(79)90061-9
  60. Sharma K, Ziyadeh FN. (1995) Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-${\beta}$ as a key mediator. Diabetes 44, 1139-1146. https://doi.org/10.2337/diabetes.44.10.1139
  61. Sharpe PC, Liu WH, Yue KK, McMaster D, Catherwood MA, McGinty AM, Trimble ER. (1998) Glucose-induced oxidative stress in vascular contractile cells: comparison of arotic smooth muscle cells and retinal pericytes. Diabetes 47, 801-809. https://doi.org/10.2337/diabetes.47.5.801
  62. Stanely Mainzen Prince P, Menon VP. (2001) Antioxidant action of Tinospora cordifolia root extract in alloxan diabetic rats. Phytother. Res. 15, 213-218. https://doi.org/10.1002/ptr.707
  63. Steffes MW, Osterby R, Chavers B, Mauer SM. (1989) Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38, 1077-1081. https://doi.org/10.2337/diabetes.38.9.1077
  64. Tesfamariam B. (1994) Free radicals in diabetic endothelial cell dysfunction. Free Radical Bio. Med. 16, 383-391. https://doi.org/10.1016/0891-5849(94)90040-X
  65. Trachtman H. (1994) Vitamin E prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Microvasc. Res. 47, 232-239. https://doi.org/10.1006/mvre.1994.1068
  66. Trachtman H, Futterweit S, Bienkowski RS. (1993) Taurine prevents glucose-induced lipid peroxidation and increased collagen production in cultured rat mesangial cells. Biochem. Bioph. Res. Co. 191, 759-765. https://doi.org/10.1006/bbrc.1993.1282
  67. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, Boles TH, Fu M, Baynes J. (1995) Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am. J. Physiol. 269, F429-F438.
  68. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li YM, Steffes M. (1994) Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats. P. Natl. Acad. Sci. USA 91, 11704-11708. https://doi.org/10.1073/pnas.91.24.11704
  69. West IC. (2000) Radicals and oxidative stress in diabetes. Diabetic Med. 17, 171-180. https://doi.org/10.1046/j.1464-5491.2000.00259.x
  70. Williams B, Gallacher B, Patel H, Orme C. (1997) Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes 46, 1497-1503. https://doi.org/10.2337/diabetes.46.9.1497
  71. Winetz JA, Golbetz HV, Spencer RJ, Lee JA, Myers BD. (1982) Glomerular function in advanced human diabetic nephropathy. Kidney Int. 21, 750-756. https://doi.org/10.1038/ki.1982.93
  72. Wohaieb SA, Godin DV. (1987) Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment. Diabetes 36, 1014-1018. https://doi.org/10.2337/diabetes.36.9.1014
  73. Yabe-Nishimura C. (1998) Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50, 21-33.
  74. Yamada T. (1992) Kinki Yauryaku, pp. 7, Kyouwa-Kikaku, Tokyo.
  75. Yaqoob M, McClelland P, Patrick AW, Stevenson A, Mason H, White MC, Bell GM. (1994) Evidence of oxidant injury and tubular damage in early diabetic nephropathy. QJM 87, 601-607.
  76. Yokozawa T, Nakagawa T, Wakaki K, Koizumi F. (2001) Animal model of diabetic nephropathy. Exp. Taxicol. Pathol. 53, 359-363. https://doi.org/10.1078/0940-2993-00203
  77. Yoshida H. (1979) Effect of Ba-wei-wan (Hachimi-gan), one of the most common traditional Chinese recipies on diabetic neuropathy. J. Jpn. Soc. Orient. Med. 29, 175-182.
  78. Ziyadeh FN, Sharma K, Ericksen M, Wolf G. (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-${\beta}$. J. Clin. Invest. 93, 536-542. https://doi.org/10.1172/JCI117004